Odonate Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020
April 28, 2020 at 05:33 pm IST
Odonate Therapeutics, Inc. announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced operating loss was USD 30.821 million compared to USD 29.222 million a year ago. Net loss was USD 30.163 million compared to USD 28.645 million a year ago. Basic loss per share from continuing operations was USD 0.99 compared to USD 1.16 a year ago.